cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.16960280
title: Additional file 3 of Expression analysis of miRNAs and their putative target genes confirm a preponderant role of transcription factors in the early response of oil palm plants to salinity stress

description: Additional file 3: Supplementary Table 3.Prediction of oil palm miRNAs-putative target genes using psRNA-Target online program, version 2, and the 79 miRNAs predicted in this study.
DOI: 10.6084/m9.figshare.16960283
title: Additional file 4 of Expression analysis of miRNAs and their putative target genes confirm a preponderant role of transcription factors in the early response of oil palm plants to salinity stress

description: Additional file 4: Supplementary Table 4. Gene ontology (GO) classification of the oil palm gene targets for orthologous and new miRNAs prospected under salinity stress. The mRNA-putative target genes were classified into biological process, molecular function, and cellular component at the second level of GO classification.
DOI: 10.6084/m9.figshare.16960280.v1
title: Additional file 3 of Expression analysis of miRNAs and their putative target genes confirm a preponderant role of transcription factors in the early response of oil palm plants to salinity stress

description: Additional file 3: Supplementary Table 3.Prediction of oil palm miRNAs-putative target genes using psRNA-Target online program, version 2, and the 79 miRNAs predicted in this study.
DOI: 10.6084/m9.figshare.16960283.v1
title: Additional file 4 of Expression analysis of miRNAs and their putative target genes confirm a preponderant role of transcription factors in the early response of oil palm plants to salinity stress

description: Additional file 4: Supplementary Table 4. Gene ontology (GO) classification of the oil palm gene targets for orthologous and new miRNAs prospected under salinity stress. The mRNA-putative target genes were classified into biological process, molecular function, and cellular component at the second level of GO classification.
DOI: 10.6084/m9.figshare.16960261.v1
title: Additional file 10 of Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression

description: Additional file 10. Neurological Disease Network identified by IPA analysis affected in the Tpp1−/− brain. DEG involved in each category are included. Each age data set is a different excel sheet.
DOI: 10.6084/m9.figshare.16960261
title: Additional file 10 of Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression

description: Additional file 10. Neurological Disease Network identified by IPA analysis affected in the Tpp1−/− brain. DEG involved in each category are included. Each age data set is a different excel sheet.
DOI: 10.6084/m9.figshare.16960267
title: Additional file 1 of Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression

description: Additional file 1. List of expressed genes identified by RNA-seq in forebrain /midbrain (F/M) and cerebellum (Cb) in Tpp1−/− mouse brains (T) versus control (N) brains at 1-, 2- and 3- and 4-month of age.
DOI: 10.6084/m9.figshare.16960267.v1
title: Additional file 1 of Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression

description: Additional file 1. List of expressed genes identified by RNA-seq in forebrain /midbrain (F/M) and cerebellum (Cb) in Tpp1−/− mouse brains (T) versus control (N) brains at 1-, 2- and 3- and 4-month of age.
DOI: 10.6084/m9.figshare.16960279
title: Additional file 5 of Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression

description: Additional file 5. Ingenuity Pathway Analysis (IPA) of genes differentially expressed in forebrain /midbrain (F/M) and cerebellum (Cb) in Tpp1−/− mouse brains versus control brains at 1-, 2- and 3- and 4-month of age. Each age data set is a different excel sheet.
DOI: 10.6084/m9.figshare.16960279.v1
title: Additional file 5 of Brain transcriptome analysis of a CLN2 mouse model as a function of disease progression

description: Additional file 5. Ingenuity Pathway Analysis (IPA) of genes differentially expressed in forebrain /midbrain (F/M) and cerebellum (Cb) in Tpp1−/− mouse brains versus control brains at 1-, 2- and 3- and 4-month of age. Each age data set is a different excel sheet.
DOI: 10.6084/m9.figshare.16822606.v1
title: Additional file 1 of Selection of medicinal plants for traditional medicines in Nepal

description: Additional file 1. Total 255 plant species with 122 medicinal species of 105 families in Baitadi and Darchula districts.
DOI: 10.6084/m9.figshare.16822612.v1
title: Additional file 3 of Selection of medicinal plants for traditional medicines in Nepal

description: Additional file 3. Regression analysis and residuals of 105 families of local district level data.
DOI: 10.6084/m9.figshare.16822606
title: Additional file 1 of Selection of medicinal plants for traditional medicines in Nepal

description: Additional file 1. Total 255 plant species with 122 medicinal species of 105 families in Baitadi and Darchula districts.
DOI: 10.6084/m9.figshare.16822609
title: Additional file 2 of Selection of medicinal plants for traditional medicines in Nepal

description: Additional file 2. Regression analysis and residuals of 231 families of national level data.
DOI: 10.6084/m9.figshare.16822609.v1
title: Additional file 2 of Selection of medicinal plants for traditional medicines in Nepal

description: Additional file 2. Regression analysis and residuals of 231 families of national level data.
DOI: 10.6084/m9.figshare.16822612
title: Additional file 3 of Selection of medicinal plants for traditional medicines in Nepal

description: Additional file 3. Regression analysis and residuals of 105 families of local district level data.
DOI: 10.6084/m9.figshare.16960324
title: Additional file 2 of IRFinder-S: a comprehensive suite to discover and explore intron retention

description: Additional file 2. Supplemental Table S1.
DOI: 10.6084/m9.figshare.16960324.v1
title: Additional file 2 of IRFinder-S: a comprehensive suite to discover and explore intron retention

description: Additional file 2. Supplemental Table S1.
DOI: 10.6084/m9.figshare.16960327
title: Additional file 3 of IRFinder-S: a comprehensive suite to discover and explore intron retention

description: Additional file 3. Supplemental Table S2.
DOI: 10.6084/m9.figshare.16960327.v1
title: Additional file 3 of IRFinder-S: a comprehensive suite to discover and explore intron retention

description: Additional file 3. Supplemental Table S2.
DOI: 10.6084/m9.figshare.16960331
title: Additional file 1 of Molecular motor KIF3B in the prelimbic cortex constrains the consolidation of contextual fear memory

description: Additional file 1. Data and statistical analyses used for preparing the figures in the manuscript.
DOI: 10.6084/m9.figshare.16960331.v1
title: Additional file 1 of Molecular motor KIF3B in the prelimbic cortex constrains the consolidation of contextual fear memory

description: Additional file 1. Data and statistical analyses used for preparing the figures in the manuscript.
DOI: 10.6084/m9.figshare.16960342
title: Additional file 4 of Frequency and characteristics of promissory conference abstracts, i.e. abstracts without results, accepted at Cochrane Colloquia 1994-2020

description: Additional file 4:. Raw data collected and analyzed within the study (available at Open Science Framework: https://osf.io/hwsa6/ ).
DOI: 10.6084/m9.figshare.16960342.v1
title: Additional file 4 of Frequency and characteristics of promissory conference abstracts, i.e. abstracts without results, accepted at Cochrane Colloquia 1994-2020

description: Additional file 4:. Raw data collected and analyzed within the study (available at Open Science Framework: https://osf.io/hwsa6/ ).
DOI: 10.6084/m9.figshare.16960346.v1
title: Additional file 2 of Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate

description: Additional file 2: Table S1. List of P. falciparum isolates with full-length sequences of the Pfs25 gene
DOI: 10.6084/m9.figshare.16960346
title: Additional file 2 of Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate

description: Additional file 2: Table S1. List of P. falciparum isolates with full-length sequences of the Pfs25 gene
DOI: 10.6084/m9.figshare.16960349
title: Additional file 3 of Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate

description: Additional file 3: Table S2. Allelic distribution of the Pfs25 gene in Plasmodium falciparum from Thailand. Abbreviations: H, the number of haplotypes; Hd, haplotype diversity index; SD, standard deviation.
DOI: 10.6084/m9.figshare.16960349.v1
title: Additional file 3 of Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate

description: Additional file 3: Table S2. Allelic distribution of the Pfs25 gene in Plasmodium falciparum from Thailand. Abbreviations: H, the number of haplotypes; Hd, haplotype diversity index; SD, standard deviation.
DOI: 10.6084/m9.figshare.16960355
title: Additional file 5 of Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate

description: Additional file 5: Table S3 Nucleotide diversity and signature of natural selection in Pfs25 in the global population of Plasmodium falciparum. Abbreviations: n, number of samples, H, the number of haplotypes; Hd, haplotype diversity index; SNP, total number of single-nucleotide polymorphism sites; nsSNP, non-synonymous SNP; ssSNP, synonymous SNP; k, average pairwise nucleotide difference between sequences; π, average nucleotide diversity at each locus; nd, not determined because of insufficient sequence data.
DOI: 10.6084/m9.figshare.16960355.v1
title: Additional file 5 of Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate

description: Additional file 5: Table S3 Nucleotide diversity and signature of natural selection in Pfs25 in the global population of Plasmodium falciparum. Abbreviations: n, number of samples, H, the number of haplotypes; Hd, haplotype diversity index; SNP, total number of single-nucleotide polymorphism sites; nsSNP, non-synonymous SNP; ssSNP, synonymous SNP; k, average pairwise nucleotide difference between sequences; π, average nucleotide diversity at each locus; nd, not determined because of insufficient sequence data.
DOI: 10.6084/m9.figshare.16960364.v1
title: Additional file 8 of Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate

description: Additional file 8: Table S4. a The list of SNPs in Pfs25 from the MalariaGen database [89]. *SNPs detected the present study. Gray and blue boxes indicate SNPs specific to P. falciparum isolates in Africa and Asia regions. b The geographical distributions of the P. falciparum isolates with polymorphic SNPs in Pfs25 in the MalariaGen database. c The estimated proportions of the H1 and non-H1 haplotypes of Pfs25 in P. falciparum populations in three continents (Asia, Africa, and South America).
DOI: 10.6084/m9.figshare.16960364
title: Additional file 8 of Global diversity of the gene encoding the Pfs25 protein—a Plasmodium falciparum transmission-blocking vaccine candidate

description: Additional file 8: Table S4. a The list of SNPs in Pfs25 from the MalariaGen database [89]. *SNPs detected the present study. Gray and blue boxes indicate SNPs specific to P. falciparum isolates in Africa and Asia regions. b The geographical distributions of the P. falciparum isolates with polymorphic SNPs in Pfs25 in the MalariaGen database. c The estimated proportions of the H1 and non-H1 haplotypes of Pfs25 in P. falciparum populations in three continents (Asia, Africa, and South America).
DOI: 10.6084/m9.figshare.16960378
title: Additional file 1 of Implementing a personalized pharmaceutical plan in kidney or liver transplant patients: study protocol for a stepped-wedge cluster randomized trial (GRePH)

description: Additional file 1. Spirit checklist.
DOI: 10.6084/m9.figshare.16960378.v1
title: Additional file 1 of Implementing a personalized pharmaceutical plan in kidney or liver transplant patients: study protocol for a stepped-wedge cluster randomized trial (GRePH)

description: Additional file 1. Spirit checklist.
DOI: 10.6084/m9.figshare.16575899
title: Additional file 1 of Prospective trial of different antimicrobial treatment durations for presumptive canine urinary tract infections

description: Additional file 1.
DOI: 10.6084/m9.figshare.16575899.v1
title: Additional file 1 of Prospective trial of different antimicrobial treatment durations for presumptive canine urinary tract infections

description: Additional file 1.
DOI: 10.6084/m9.figshare.16960510
title: Additional file 1 of VarGoats project: a dataset of 1159 whole-genome sequences to dissect Capra hircus global diversity

description: Additional file 1: Table S1. Number of individuals per breed and country of origin. Distribution of sequenced individuals per breed and description of the abbreviations corresponding to each population.
DOI: 10.6084/m9.figshare.16960510.v1
title: Additional file 1 of VarGoats project: a dataset of 1159 whole-genome sequences to dissect Capra hircus global diversity

description: Additional file 1: Table S1. Number of individuals per breed and country of origin. Distribution of sequenced individuals per breed and description of the abbreviations corresponding to each population.
DOI: 10.6084/m9.figshare.16960513
title: Additional file 2 of VarGoats project: a dataset of 1159 whole-genome sequences to dissect Capra hircus global diversity

description: Additional file 2: Table S2. Detailed information for each sequenced individual. Description of each individual (species, breed, country of origin, localization, sex, sample provider and details on its associated sequence).
DOI: 10.6084/m9.figshare.16960513.v1
title: Additional file 2 of VarGoats project: a dataset of 1159 whole-genome sequences to dissect Capra hircus global diversity

description: Additional file 2: Table S2. Detailed information for each sequenced individual. Description of each individual (species, breed, country of origin, localization, sex, sample provider and details on its associated sequence).
DOI: 10.6084/m9.figshare.16960534
title: Additional file 7 of VarGoats project: a dataset of 1159 whole-genome sequences to dissect Capra hircus global diversity

description: Additional file 7. Tranche summary file produced by VariantRecalibrator for SNPs. File of comma-separated values for tranches 0 to 90, 90 to 99, 99 to 99.9 and 99.9 to 100.
DOI: 10.6084/m9.figshare.16960534.v1
title: Additional file 7 of VarGoats project: a dataset of 1159 whole-genome sequences to dissect Capra hircus global diversity

description: Additional file 7. Tranche summary file produced by VariantRecalibrator for SNPs. File of comma-separated values for tranches 0 to 90, 90 to 99, 99 to 99.9 and 99.9 to 100.
DOI: 10.6084/m9.figshare.16960537
title: Additional file 8 of VarGoats project: a dataset of 1159 whole-genome sequences to dissect Capra hircus global diversity

description: Additional file 8. Tranche summary file produced by VariantRecalibrator for InDels. File of comma-separated values for tranches 0 to 90, 90 to 99, 99 to 99.9 and 99.9 to 100.
DOI: 10.6084/m9.figshare.16960537.v1
title: Additional file 8 of VarGoats project: a dataset of 1159 whole-genome sequences to dissect Capra hircus global diversity

description: Additional file 8. Tranche summary file produced by VariantRecalibrator for InDels. File of comma-separated values for tranches 0 to 90, 90 to 99, 99 to 99.9 and 99.9 to 100.
DOI: 10.6084/m9.figshare.16960580
title: Additional file 2 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 2: Table S1. Lists of significant DEGs (p
DOI: 10.6084/m9.figshare.16960580.v1
title: Additional file 2 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 2: Table S1. Lists of significant DEGs (p
DOI: 10.6084/m9.figshare.16960583
title: Additional file 3 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 3: Table S2. Differential gene expression in astrocyte group (related to Fig. 2).
DOI: 10.6084/m9.figshare.16960583.v1
title: Additional file 3 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 3: Table S2. Differential gene expression in astrocyte group (related to Fig. 2).
DOI: 10.6084/m9.figshare.16960586
title: Additional file 4 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 4: Table S3. Cell number of Olig2-positive/GFAP-positive, Olig2-positive/GFAP-negative, Olig2-negative/GFAP-positive, Olig2-negative/GFAP-negative cells, in each group of Astrocytes.
DOI: 10.6084/m9.figshare.16960586.v1
title: Additional file 4 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 4: Table S3. Cell number of Olig2-positive/GFAP-positive, Olig2-positive/GFAP-negative, Olig2-negative/GFAP-positive, Olig2-negative/GFAP-negative cells, in each group of Astrocytes.
DOI: 10.6084/m9.figshare.16960589
title: Additional file 5 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 5: Table S4. Gene ontology (GO) terms (biological process) of A1 group by GO analysis (related to Fig. 2d).
DOI: 10.6084/m9.figshare.16960592
title: Additional file 6 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 6: Table S5. 416 genes that were significantly expressed in Olig2-astrocytes rather than GFAP-astrocytes (p
DOI: 10.6084/m9.figshare.16960595.v1
title: Additional file 7 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 7: Table S6. Solute carrier (SLC) genes extracted from the 416 genes whose expression was significantly biased to Olig2-astrocytes as compared to GFAP-astrocytes (Table S5) (related to Fig. 2e).
DOI: 10.6084/m9.figshare.16960589.v1
title: Additional file 5 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 5: Table S4. Gene ontology (GO) terms (biological process) of A1 group by GO analysis (related to Fig. 2d).
DOI: 10.6084/m9.figshare.16960595
title: Additional file 7 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 7: Table S6. Solute carrier (SLC) genes extracted from the 416 genes whose expression was significantly biased to Olig2-astrocytes as compared to GFAP-astrocytes (Table S5) (related to Fig. 2e).
DOI: 10.6084/m9.figshare.16960592.v1
title: Additional file 6 of Olig2-astrocytes express neutral amino acid transporter SLC7A10 (Asc-1) in the adult brain

description: Additional file 6: Table S5. 416 genes that were significantly expressed in Olig2-astrocytes rather than GFAP-astrocytes (p
DOI: 10.6084/m9.figshare.16960606
title: Additional file 2 of Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine

description: Additional file 2:. Table S1. Table S1. List of purity- and ploidy status of the discovery cohort. Table S2. Sequencing statistics. Table S3. Primer sequences used for Sanger sequencing, pyrosequencing and ddPCR™. Table S4. Sanger sequencing, pyrosequencing and ddPCR™ were used to validate single nucleotide variations detected by whole-exome sequencing. Table S5. List of non-synonymous mutations found in the discovery cohort. Table S6. List of synonymous mutations found in the discovery cohort. Table S7. List of genes with non-synonymous mutations present in the primary tumor of case #5 and its lymph node metastases. Table S8. Distribution of the copy number variants (CNVs), i.e., homozygous or heterozygous deletion and amplification among the 48 tumor samples of the discovery cohort. Table S9. List of cancer cell fraction (CCF) non-synonymous mutations. Table S10. List of genes with ≥2 non-synonymous mutations per case. Table S11. Pathway analysis including copy number variation on the discovery cohort. Table S12. Multivariate analysis. Table S13. Comparison of the prevalence of the single nucleotide variations discovered in our test cohort with published data on gastric cancer [3, 5, 7, 56]. Table S14. List of genes with non-synonymous mutations present in ≥2 cases of the discovery cohort.
DOI: 10.6084/m9.figshare.16960606.v1
title: Additional file 2 of Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine

description: Additional file 2:. Table S1. Table S1. List of purity- and ploidy status of the discovery cohort. Table S2. Sequencing statistics. Table S3. Primer sequences used for Sanger sequencing, pyrosequencing and ddPCR™. Table S4. Sanger sequencing, pyrosequencing and ddPCR™ were used to validate single nucleotide variations detected by whole-exome sequencing. Table S5. List of non-synonymous mutations found in the discovery cohort. Table S6. List of synonymous mutations found in the discovery cohort. Table S7. List of genes with non-synonymous mutations present in the primary tumor of case #5 and its lymph node metastases. Table S8. Distribution of the copy number variants (CNVs), i.e., homozygous or heterozygous deletion and amplification among the 48 tumor samples of the discovery cohort. Table S9. List of cancer cell fraction (CCF) non-synonymous mutations. Table S10. List of genes with ≥2 non-synonymous mutations per case. Table S11. Pathway analysis including copy number variation on the discovery cohort. Table S12. Multivariate analysis. Table S13. Comparison of the prevalence of the single nucleotide variations discovered in our test cohort with published data on gastric cancer [3, 5, 7, 56]. Table S14. List of genes with non-synonymous mutations present in ≥2 cases of the discovery cohort.
DOI: 10.6084/m9.figshare.16960622
title: Additional file 1 of Comparison of bone and articular cartilage changes in osteoarthritis: a micro-computed tomography and histological study of surgically and chemically induced osteoarthritic rabbit models

description: Additional file 1: Supplementary p-values. p-values for micro-CT parameters and histological scoring statistical analysis.
DOI: 10.6084/m9.figshare.16960625
title: Additional file 1 of Genome-wide survey and identification of AP2/ERF genes involved in shoot and leaf development in Liriodendron chinense

description: Additional file 1: Table S1. List of the 104 AP2/ERF genes identified in L. chinense.
DOI: 10.6084/m9.figshare.16960622.v1
title: Additional file 1 of Comparison of bone and articular cartilage changes in osteoarthritis: a micro-computed tomography and histological study of surgically and chemically induced osteoarthritic rabbit models

description: Additional file 1: Supplementary p-values. p-values for micro-CT parameters and histological scoring statistical analysis.
DOI: 10.6084/m9.figshare.16960625.v1
title: Additional file 1 of Genome-wide survey and identification of AP2/ERF genes involved in shoot and leaf development in Liriodendron chinense

description: Additional file 1: Table S1. List of the 104 AP2/ERF genes identified in L. chinense.
DOI: 10.6084/m9.figshare.16960628
title: Additional file 2 of Genome-wide survey and identification of AP2/ERF genes involved in shoot and leaf development in Liriodendron chinense

description: Additional file 2: Table S2. List of primer sequences in this study.